Skip to main content
Erschienen in: International Urology and Nephrology 3/2010

01.09.2010 | Urology - Original Paper

Comparison of the differences in circadian autonomic function in hyperlipidemic men with and without erectile dysfunction

verfasst von: M. Tolga Dogru, M. Murad Basar

Erschienen in: International Urology and Nephrology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

We aimed to investigate differences in circadian autonomic changes in patients suffering from hyperlipidemia with and without erectile dysfunction and compared results to control cases.

Materials and methods

A total of 77 patients (age range: 24–74, mean age: 45.3 ± 9.3) with uncontrolled hyperlipidemia (total cholesterol >200 mg/dL and/or LDL >160 mg/dL despite a regular diet) were enrolled into the study. These patients were divided into two groups according to their International Index of Erectile Function (IIEF-EF) scores as having erectile dysfunction (IIEF-EF < 26) (Group 1) or as having normal erectile function (IIEF-EF ≥ 26) (Group 2). In addition, the control group comprised 44 healthy men (age range: 20–57, mean age: 44.0 ± 10.8) (Group 3). Heart rate variability parameters obtained by 24-h Holter monitoring were utilized for the indirect evaluation of autonomic function.

Results

There were statistically significant differences between the groups with respect to daytime and nocturnal autonomic activity (p < 0.005). Moreover, Group 1 had lower nocturnal parasympathetic and higher nocturnal sympathetic activity compared to the other groups (for nocturnal HFn p 1-2 < 0.001; p 1-3 < 0.001; p 2-3 > 0.05; for nocturnal LFn p 1-2 < 0.001; p 1-3 < 0.001; p 2-3 > 0.05).

Conclusion

We concluded that hyperlipidemia results in deterioration of autonomic circadian rhythm. Hyperlipidemic patients with erectile dysfunction had diminished nocturnal parasympathetic activities.
Literatur
1.
Zurück zum Zitat Seftel AD, Sun P, Swindle R (2004) The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 171:2341–2345CrossRefPubMed Seftel AD, Sun P, Swindle R (2004) The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 171:2341–2345CrossRefPubMed
2.
Zurück zum Zitat Roumeguere TH, Wespes E, Carpentier Y et al (2003) Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol 44:355–359CrossRefPubMed Roumeguere TH, Wespes E, Carpentier Y et al (2003) Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol 44:355–359CrossRefPubMed
3.
Zurück zum Zitat Kim JH, Klyachkin ML, Svendsen E et al (1994) Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. J Urol 151:198–205PubMed Kim JH, Klyachkin ML, Svendsen E et al (1994) Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. J Urol 151:198–205PubMed
4.
Zurück zum Zitat Urbancic-Rovan V, Meglic B, Stefanovska A et al (2007) Incipient cardiovascular autonomic imbalance revealed by wavelet analysis of heart rate variability in Type 2 diabetic patients. Diabet Med 24:18–26CrossRefPubMed Urbancic-Rovan V, Meglic B, Stefanovska A et al (2007) Incipient cardiovascular autonomic imbalance revealed by wavelet analysis of heart rate variability in Type 2 diabetic patients. Diabet Med 24:18–26CrossRefPubMed
5.
Zurück zum Zitat Fagard RH, Stolarz K, Kuznetsova T et al (2007) Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension. J Hypertens 25:2280–2285CrossRefPubMed Fagard RH, Stolarz K, Kuznetsova T et al (2007) Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension. J Hypertens 25:2280–2285CrossRefPubMed
6.
Zurück zum Zitat Doncheva NI, Nikolova RI, Danev SG (2003) Overweight, dyslipoproteinemia, and heart rate variability measures. Folia Med (Plovdiv) 45:8–12 Doncheva NI, Nikolova RI, Danev SG (2003) Overweight, dyslipoproteinemia, and heart rate variability measures. Folia Med (Plovdiv) 45:8–12
7.
Zurück zum Zitat Ragot S, Herpin D, Siché JP et al. (1999). Autonomic nervous system activity in dipper and non-dipper essential hypertensive patients. What about sex differences? J Hypertens 17 (12 Pt2): 1805–1811. Ragot S, Herpin D, Siché JP et al. (1999). Autonomic nervous system activity in dipper and non-dipper essential hypertensive patients. What about sex differences? J Hypertens 17 (12 Pt2): 1805–1811.
8.
Zurück zum Zitat Perciaccante A, Fiorentini A, Paris A et al (2006) Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovasc Disord 6:19CrossRefPubMed Perciaccante A, Fiorentini A, Paris A et al (2006) Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovasc Disord 6:19CrossRefPubMed
9.
Zurück zum Zitat Maser RE, Lenhard MJ (2005) Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab 90:5896–5903CrossRefPubMed Maser RE, Lenhard MJ (2005) Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab 90:5896–5903CrossRefPubMed
10.
Zurück zum Zitat Vinik AI, Maser RE, Mitchell BD et al (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579CrossRefPubMed Vinik AI, Maser RE, Mitchell BD et al (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579CrossRefPubMed
11.
Zurück zum Zitat Lavie P, Shlitner A, Nave R (1999) Cardiac autonomic function during sleep in psychogenic and organic erectile dysfunction. J Sleep Res 8:135–142CrossRefPubMed Lavie P, Shlitner A, Nave R (1999) Cardiac autonomic function during sleep in psychogenic and organic erectile dysfunction. J Sleep Res 8:135–142CrossRefPubMed
12.
Zurück zum Zitat David DS (1999). Hypercholesterolemia, abnormal coronary vasomotion and calcium antagonist. Circulation 99: 1922. David DS (1999). Hypercholesterolemia, abnormal coronary vasomotion and calcium antagonist. Circulation 99: 1922.
13.
Zurück zum Zitat Brook RD Julius S (2000) Autonomic imbalance, hypertension and cardiovascular risk. Am J Hypertens 13 (6 Pt 2): 112S–122S. Brook RD Julius S (2000) Autonomic imbalance, hypertension and cardiovascular risk. Am J Hypertens 13 (6 Pt 2): 112S–122S.
14.
Zurück zum Zitat Palatini P, Longo D, Zaetta V et al (2006) Evaluation of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity. J Hypertens 24:1375–1381CrossRefPubMed Palatini P, Longo D, Zaetta V et al (2006) Evaluation of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity. J Hypertens 24:1375–1381CrossRefPubMed
15.
Zurück zum Zitat Basar MM, Atan A, Tekdogan UY (2001) New concept parameters of RigiScan in differentiation of vascular erectile dysfunction: is it a useful test? Int J Urol 8:686–691CrossRefPubMed Basar MM, Atan A, Tekdogan UY (2001) New concept parameters of RigiScan in differentiation of vascular erectile dysfunction: is it a useful test? Int J Urol 8:686–691CrossRefPubMed
16.
Zurück zum Zitat Bax G, Marin N, Piarulli F et al (1998) Rigiscan evaluation of specific nervous impairment in patients with diabetes and erectile disorders. Diabetes Care 21:1159–1161CrossRefPubMed Bax G, Marin N, Piarulli F et al (1998) Rigiscan evaluation of specific nervous impairment in patients with diabetes and erectile disorders. Diabetes Care 21:1159–1161CrossRefPubMed
17.
Zurück zum Zitat No authors listed (1996) Heart rate variability: standards of measurement, physiological interpretation, and clinical use Task Force of the European Society of Cardiology (ESC) and the North American Society of Pacing and Electrophysiology (NASPE). Circulation 93:1043–1065 No authors listed (1996) Heart rate variability: standards of measurement, physiological interpretation, and clinical use Task Force of the European Society of Cardiology (ESC) and the North American Society of Pacing and Electrophysiology (NASPE). Circulation 93:1043–1065
18.
Zurück zum Zitat Matsumoto T, Miyatsuji A, Miyawaki T et al (2003) Potential association between endogenous leptin and sympathovagal activities in young obese Japanese women. Am. J Hum Biol 15:8–15CrossRefPubMed Matsumoto T, Miyatsuji A, Miyawaki T et al (2003) Potential association between endogenous leptin and sympathovagal activities in young obese Japanese women. Am. J Hum Biol 15:8–15CrossRefPubMed
19.
Zurück zum Zitat Acharya UR, Kannathal N, Sing OW et al (2004) Heart rate analysis in normal subjects of various age groups. Biomed Eng Online 3:24CrossRef Acharya UR, Kannathal N, Sing OW et al (2004) Heart rate analysis in normal subjects of various age groups. Biomed Eng Online 3:24CrossRef
20.
Zurück zum Zitat Kupari M, Virolainen J, Koskinen P et al (1993) Short-term heart rate variability and factors modifying the risk of coronary artery disease in a population sample. Am J Cardiol 72:897–903CrossRefPubMed Kupari M, Virolainen J, Koskinen P et al (1993) Short-term heart rate variability and factors modifying the risk of coronary artery disease in a population sample. Am J Cardiol 72:897–903CrossRefPubMed
21.
Zurück zum Zitat Benaa KH, Arnesen E (1999) Association between heart rate and atherogenic blood lipid fractions in a population. The Tromse study. Circulation S6:394–405 Benaa KH, Arnesen E (1999) Association between heart rate and atherogenic blood lipid fractions in a population. The Tromse study. Circulation S6:394–405
22.
Zurück zum Zitat Kawanishi Y, Lee KS, Kimura K et al (2001) Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients. Int J Impot Res 13:100–103CrossRefPubMed Kawanishi Y, Lee KS, Kimura K et al (2001) Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients. Int J Impot Res 13:100–103CrossRefPubMed
23.
Zurück zum Zitat Ferini-Strambi L, Zucconi M, Rigatti P et al (1992) Male impotence: a possible beta-adrenergic dysfunction in some patients. Eur Urol 21:332–334PubMed Ferini-Strambi L, Zucconi M, Rigatti P et al (1992) Male impotence: a possible beta-adrenergic dysfunction in some patients. Eur Urol 21:332–334PubMed
24.
Zurück zum Zitat Braun M, Wassmer G, Klotz T et al (2000) Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res 12:305–311CrossRefPubMed Braun M, Wassmer G, Klotz T et al (2000) Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res 12:305–311CrossRefPubMed
25.
Zurück zum Zitat Jünemann KP, Aufenanger J, Konrad T et al (1991) The effect of impaired lipid metabolism on the smooth muscle cells of rabbits. Urol Res 19:271–275CrossRefPubMed Jünemann KP, Aufenanger J, Konrad T et al (1991) The effect of impaired lipid metabolism on the smooth muscle cells of rabbits. Urol Res 19:271–275CrossRefPubMed
26.
Zurück zum Zitat Chowienczyk PJ, Watts GF, Cockcroft JR et al (1992) Impaired endothelium-dependent vasodilation of the forearm resistance vessels in hypercholesterolaemia. Lancet 340:1430–1432CrossRefPubMed Chowienczyk PJ, Watts GF, Cockcroft JR et al (1992) Impaired endothelium-dependent vasodilation of the forearm resistance vessels in hypercholesterolaemia. Lancet 340:1430–1432CrossRefPubMed
27.
Zurück zum Zitat Egashira K, Hirooka Y, Kai H et al (1994) Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89:2519–2524PubMed Egashira K, Hirooka Y, Kai H et al (1994) Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89:2519–2524PubMed
28.
Zurück zum Zitat O’Driscoll G, Green D, Taylor RR (1997) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95:1126–1131PubMed O’Driscoll G, Green D, Taylor RR (1997) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95:1126–1131PubMed
29.
Zurück zum Zitat Christensen JH, Toft E, Christensen MS et al (1999) Heart rate variability and plasma lipids in men with and without ischaemic heart disease. Atherosclerosis 145:181–186CrossRefPubMed Christensen JH, Toft E, Christensen MS et al (1999) Heart rate variability and plasma lipids in men with and without ischaemic heart disease. Atherosclerosis 145:181–186CrossRefPubMed
30.
Zurück zum Zitat Takagi T, Ohishi M, Ito N et al (2006) Evaluation of morning blood pressure elevation and autonomic nervous activity in hypertensive patients using wavelet transform of heart rate variability. Hypertens Res 29:977–987CrossRefPubMed Takagi T, Ohishi M, Ito N et al (2006) Evaluation of morning blood pressure elevation and autonomic nervous activity in hypertensive patients using wavelet transform of heart rate variability. Hypertens Res 29:977–987CrossRefPubMed
31.
Zurück zum Zitat Burger AJ, Charlamb M, Sherman HB (1999) Circadian patterns of heart rate variability in normals, chronic stable angina and diabetes mellitus. Int J Cardiol 71:41–48CrossRefPubMed Burger AJ, Charlamb M, Sherman HB (1999) Circadian patterns of heart rate variability in normals, chronic stable angina and diabetes mellitus. Int J Cardiol 71:41–48CrossRefPubMed
32.
Zurück zum Zitat Giuliano F, Rampin O (2000) Central neural regulation of penile erection. Neurosci Biobehav Rev 24:517–533CrossRefPubMed Giuliano F, Rampin O (2000) Central neural regulation of penile erection. Neurosci Biobehav Rev 24:517–533CrossRefPubMed
33.
Zurück zum Zitat Broderick GA (1998) Evidence based assessment of erectile dysfunction. Int J Impot Res 10:S64–S73PubMed Broderick GA (1998) Evidence based assessment of erectile dysfunction. Int J Impot Res 10:S64–S73PubMed
Metadaten
Titel
Comparison of the differences in circadian autonomic function in hyperlipidemic men with and without erectile dysfunction
verfasst von
M. Tolga Dogru
M. Murad Basar
Publikationsdatum
01.09.2010
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 3/2010
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9658-2

Weitere Artikel der Ausgabe 3/2010

International Urology and Nephrology 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.